1. MicroRNA-543 acts as a prognostic marker and promotes the cell proliferation in cervical cancer by BRCA1-interacting protein 1
   Huimin Dang et al, 2017, Tumor Biology CrossRef
2. Knockdown of RhoE Expression Enhances TGF-β-Induced EMT (epithelial-to-mesenchymal transition) in Cervical Cancer HeLa Cells
   Makoto Nishizuka et al, 2019, International Journal of Molecular Sciences CrossRef
3. Microwave assists synthesis of spirothiazolidine derivatives to induce cervical cancer cell death-mediated apoptosis in vitro
   Walaa I. El-Sofany et al, 2023, Journal of Molecular Structure CrossRef
4. The genetic characterization of germplasm and identification of the litter size trait associated candidate genes in Dexin mutton and fine-wool sheep
   Mengting Zhu et al, 2024, Frontiers in Genetics CrossRef
5. The repair gene BACH1 - a potential oncogene
   Katheeja Muhseena N et al, 2021, Oncology Reviews CrossRef
6. Cervical cancer stem‐like cells: systematic review and identification of reference genes for gene expression
   Rafael P. de Campos et al, 2018, Cell Biology International CrossRef
7. Fundamental Boolean network modelling for childhood acute lymphoblastic leukaemia pathways
   Leshi Chen et al, 2022, Quantitative Biology CrossRef
8. Metaformin-Based Regimen Inhibits Glucose Uptake and G6PD Activity: A de novo Anti-cervical Cancer Strategy Tackles HeLa and its Derivative Hep2 Cells
   Ahmed A. Abd-Rabou et al, 2017, Journal of Pharmacology and Toxicology CrossRef
9. RhoA regulates lipopolysaccharide-induced lung cell injury via the Wnt/β-catenin pathway
   Guanhua Chen et al, 2017, Molecular Medicine Reports CrossRef
10. Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer
    Fangfang Xu et al, 2022, Frontiers in Immunology CrossRef
11. Gα12/13 signaling promotes cervical cancer invasion through the RhoA/ROCK-JNK signaling axis
    Bo Yuan et al, 2016, Biochemical and Biophysical Research Communications CrossRef
12. Prognostic Value Estimation of BRIP1 in Breast Cancer by Exploiting Transcriptomics Data Through Bioinformatics Approaches
    Umama Khan et al, 2021, Bioinformatics and Biology Insights CrossRef
13. BRIP1coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease
    Abderrahim Oussalah et al, 2017, Oncotarget CrossRef
14. Andrographolide induces DNA damage in prostate cancer cells
    Ingrid S. Forestier-Román et al, 2019, Oncotarget CrossRef
15. Discovery of pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and molecular modeling investigations
    Ibrahim F. Nassar et al, 2022, RSC Advances CrossRef
16. Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
    Asmaa A. Mandour et al, 2022, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
17. Novel role of BRCA1 interacting C‐terminal helicase 1 (BRIP1) in breast tumour cell invasion
    Balsam Rizeq et al, 2020, Journal of Cellular and Molecular Medicine CrossRef